Show simple item record

dc.contributor.authorSchulz, A
dc.contributor.authorBüttner, R
dc.contributor.authorHagel, C
dc.contributor.authorBaader, SL
dc.contributor.authorKluwe, L
dc.contributor.authorSalamon, J
dc.contributor.authorMautner, VF
dc.contributor.authorMindos, T
dc.contributor.authorParkinson, DB
dc.contributor.authorGehlhausen, JR
dc.contributor.authorClapp, DW
dc.contributor.authorMorrison, H
dc.date.accessioned2016-06-10T08:33:47Z
dc.date.accessioned2016-08-30T13:59:50Z
dc.date.available2016-06-10T08:33:47Z
dc.date.issued2016-05-28
dc.identifier.issn0001-6322
dc.identifier.issn1432-0533
dc.identifier.urihttp://hdl.handle.net/10026.1/5394
dc.description.abstract

Schwannomas are predominantly benign nerve sheath neoplasms caused by Nf2 gene inactivation. Presently, treatment options are mainly limited to surgical tumor resection due to the lack of effective pharmacological drugs. Although the mechanistic understanding of Nf2 gene function has advanced, it has so far been primarily restricted to Schwann cell-intrinsic events. Extracellular cues determining Schwann cell behavior with regard to schwannoma development remain unknown. Here we show pro-tumourigenic microenvironmental effects on Schwann cells where an altered axonal microenvironment in cooperation with injury signals contribute to a persistent regenerative Schwann cell response promoting schwannoma development. Specifically in genetically engineered mice following crush injuries on sciatic nerves, we found macroscopic nerve swellings in mice with homozygous nf2 gene deletion in Schwann cells and in animals with heterozygous nf2 knockout in both Schwann cells and axons. However, patient-mimicking schwannomas could only be provoked in animals with combined heterozygous nf2 knockout in Schwann cells and axons. We identified a severe re-myelination defect and sustained macrophage presence in the tumor tissue as major abnormalities. Strikingly, treatment of tumor-developing mice after nerve crush injury with medium-dose aspirin significantly decreased schwannoma progression in this disease model. Our results suggest a multifactorial concept for schwannoma formation-emphasizing axonal factors and mechanical nerve irritation as predilection site for schwannoma development. Furthermore, we provide evidence supporting the potential efficacy of anti-inflammatory drugs in the treatment of schwannomas.

dc.format.extent289-307
dc.format.mediumPrint-Electronic
dc.languageen
dc.language.isoen
dc.publisherSpringer Science and Business Media LLC
dc.relation.replaceshttp://hdl.handle.net/10026.1/4875
dc.relation.replaces10026.1/4875
dc.subjectSchwannoma
dc.subjectNeurofibromatosis type 2
dc.subjectNF2
dc.subjectTumor induction
dc.subjectMicroenvironment
dc.subjectSciatic nerve
dc.subjectCrush injury
dc.subjecttissue inflammation
dc.titleThe importance of nerve microenvironment for schwannoma development
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/27236462
plymouth.issue2
plymouth.volume132
plymouth.publication-statusPublished
plymouth.journalActa neuropathologica
dc.identifier.doi10.1007/s00401-016-1583-8
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Researchers in ResearchFish submission
dc.publisher.placeGermany
dcterms.dateAccepted2016-05-21
dc.rights.embargodate2017-5-28
dc.identifier.eissn1432-0533
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1007/s00401-016-1583-8
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2016-05-28
rioxxterms.typeJournal Article/Review
plymouth.funderInteraction between Sox-10 and the tumour suppressor Merlin in tumours of the nervous system.::MRC
plymouth.oa-locationhttps://link.springer.com/article/10.1007/s00401-016-1583-8


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV